- Home
- CROX vs CRL Comparison
CROX vs CRL Comparison
Compare CROX & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CROX
- CRL
- Stock Information
- Founded
- CROX 1999
- CRL 1947
- Country
- CROX United States
- CRL United States
- Employees
- CROX N/A
- CRL N/A
- Industry
- CROX Shoe Manufacturing
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CROX Consumer Discretionary
- CRL Health Care
- Exchange
- CROX Nasdaq
- CRL Nasdaq
- Market Cap
- CROX 5.7B
- CRL 6.8B
- IPO Year
- CROX 2006
- CRL 2000
- Fundamental
- Price
- CROX $98.52
- CRL $147.44
- Analyst Decision
- CROX Strong Buy
- CRL Hold
- Analyst Count
- CROX 12
- CRL 15
- Target Price
- CROX $133.45
- CRL $186.38
- AVG Volume (30 Days)
- CROX 1.3M
- CRL 764.6K
- Earning Date
- CROX 07-31-2025
- CRL 08-06-2025
- Dividend Yield
- CROX N/A
- CRL N/A
- EPS Growth
- CROX 26.25
- CRL N/A
- EPS
- CROX 16.31
- CRL N/A
- Revenue
- CROX $4,100,808,000.00
- CRL $4,022,597,000.00
- Revenue This Year
- CROX $3.04
- CRL N/A
- Revenue Next Year
- CROX $2.96
- CRL $2.47
- P/E Ratio
- CROX $6.04
- CRL N/A
- Revenue Growth
- CROX 2.09
- CRL N/A
- 52 Week Low
- CROX $86.11
- CRL $91.86
- 52 Week High
- CROX $165.32
- CRL $254.15
- Technical
- Relative Strength Index (RSI)
- CROX 41.71
- CRL 57.46
- Support Level
- CROX $96.75
- CRL $143.06
- Resistance Level
- CROX $103.02
- CRL $154.43
- Average True Range (ATR)
- CROX 2.86
- CRL 4.61
- MACD
- CROX -0.56
- CRL -0.18
- Stochastic Oscillator
- CROX 17.13
- CRL 68.01
About CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company are the United States and other Countries.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.